Loading data for PYPD — first visit, this takes a few seconds.
PolyPid Ltd. (PYPD)
NasdaqCM: PYPD
· 即時價格 · USD
5.15
-0.01 (-0.19%)
收盤價： Sep 10, 2026, 3:59 PM
股價、關鍵數字和最新消息，都在這一頁。
PolyPid Ltd.（PYPD）股價、分析與資料
-0.19% (1D)
| 買價 | 3.66 |
| 市值 | 105M |
| 營收 (ttm) | n/a |
| 淨利（ttm） | -31.5M |
| 1.42 | |
| -1.3 | |
| n/a | |
| -4.2 | |
| P/B (ttm) | 19.47 |
| P/S (ttm) | 0.00 |
| 財報日期 | Nov 11, 2026 |
| 賣價 | 6.55 |
| 成交量 | 99,332 |
| 20 日平均成交量 | 215,274 |
| 開盤價 | 5.20 |
| 前收盤價 | 5.16 |
| 當日區間 | 5.04 - 5.24 |
| 52 週範圍 | 3.06 - 5.73 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 PYPD
PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The comp...
完整的公司簡介財報驚奇
PolyPid 已於 Aug 12, 2026 公布季度財報：
- 營收為 $0 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 -0.35 超出預期 0.03, 年增 55.13% 成長.
第 1 頁，共 2 頁